Sartorius Stedim Biotech strives to enable its shareholders to participate adequately in the company’s success and has continuously increased its dividend in recent years. In line with this objective, we basically follow the policy of paying out a relatively stable share of relevant net profit to our shareholders.
|Total dividends paid in millions of €||18.4||20.0||30.7||38.7||42.4|
|Payout ratio1 in %||24.5||22.9||22.1||21.9||23.5|
|Dividend yield2 in %||1.0||0.8||0.6||0.7||0.8|
1 Based on the underlying net result 2 Dividends in relation to the corresponding closing prices of the year